Oxford BioDynamics (STU:LMQ) FCF Margin %: -545.47% (As of Sep. 2025)


What is Oxford BioDynamics FCF Margin %?

Oxford BioDynamics STU:LMQ FCF Margin % is -545.47% as of Sep. 2025. The stock has 4 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Oxford BioDynamics ranks worse than 92.65% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Oxford BioDynamics's Free Cash Flow for the six months ended in Sep. 2025 was €-3.19 Mil. Oxford BioDynamics's Revenue for the six months ended in Sep. 2025 was €0.59 Mil. Therefore, Oxford BioDynamics's FCF Margin % for the quarter that ended in Sep. 2025 was -545.47%.

As of today, Oxford BioDynamics's current FCF Yield % is -105.24%.

The historical rank and industry rank for Oxford BioDynamics's FCF Margin % or its related term are showing as below:

STU:LMQ' s FCF Margin % Range Over the Past 10 Years
Min: -3946.75   Med: -779.97   Max: -142.62
Current: -716.47

During the past 13 years, the highest FCF Margin % of Oxford BioDynamics was -142.62%. The lowest was -3946.75%. And the median was -779.97%.

STU:LMQ's FCF Margin % is ranked worse than
92.65% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: -1.845 vs STU:LMQ: -716.47

Oxford BioDynamics FCF Margin % Related Terms

Oxford BioDynamics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Oxford BioDynamics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oxford BioDynamics FCF Margin % Chart

Oxford BioDynamics Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,642.46 -3,950.57 -1,767.85 -1,692.88 -713.72

Oxford BioDynamics Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,217.26 -1,151.05 -2,268.48 -858.97 -545.47

STU:LMQ vs TMO, DHR, IDXX: FCF Margin % Comparison

For the Diagnostics & Research subindustry, Oxford BioDynamics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxford BioDynamics FCF Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Oxford BioDynamics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Oxford BioDynamics's FCF Margin % falls into.


Oxford BioDynamics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Oxford BioDynamics's FCF Margin for the fiscal year that ended in Sep. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Sep. 2025 )/Revenue (A: Sep. 2025 )
=-9/1.261
=-713.72 %

Oxford BioDynamics's FCF Margin for the quarter that ended in Sep. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Sep. 2025 )/Revenue (Q: Sep. 2025 )
=-3.191/0.585
=-545.47 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -545.47% mean?
Oxford BioDynamics (STU:LMQ) has a FCF Margin % of -545.47% as of Sep. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Oxford BioDynamics and its competitors. According to the industry distribution chart, Oxford BioDynamics ranks #189 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 92.6%.
Is Oxford BioDynamics' FCF Margin % too high?
Oxford BioDynamics' current FCF Margin % is -545.47%. Based on the distribution chart, Oxford BioDynamics ranks #189 out of 204 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Oxford BioDynamics' FCF Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Oxford BioDynamics ranks #189 out of 204 companies for FCF Margin %. This places Oxford BioDynamics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Diagnostics & Research company?
A good FCF Margin % depends on the Medical Diagnostics & Research industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Oxford BioDynamics and its competitors. Oxford BioDynamics's current FCF Margin % is -545.47%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oxford BioDynamics stock overvalued right now?
Based on GuruFocus' analysis, Oxford BioDynamics (STU:LMQ) is currently considered Possible Value Trap. The stock's GF Value™ is €0.01, compared to a current price of €0.00 — trading 95% below its estimated fair value. The current FCF Margin % is -545.47%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Oxford BioDynamics (STU:LMQ), the current FCF Margin % is -545.47% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oxford BioDynamics Business Description

Other Exchanges OXBOF:USAOBD:UK
Address John Smith Drive, 3140 Rowan Place, Oxford Business Park South, Oxford, GBR, OX4 2WB
Oxford BioDynamics PLC is a biotechnology company focused on advancing personalized healthcare through the development and commercialization of precision medicine tests for serious and impactful diseases. The company is engaged in the commercialisation of proprietary molecular diagnostics products and biomarker research and development. It has two commercially available products: the EpiSwitch PSE (EpiSwitch Prostate Cancer Detection Test) and EpiSwitch CiRT (Checkpoint Inhibitor Response Test) blood tests. The company generates revenue from the sales of proprietary products and biomarker research and development. Geographically, it generates the maximum revenue from the USA.